India, Nov. 3 -- Dutch healthcare technology company Koninklijke Philips N.V. (PHGFF.PK,PHG) reported Tuesday a rise in its sales for the third quarter, with a growth in adjusted EBITDA. Comparable order intake was higher than last year. Further, the firm maintained fiscal 2026 outlook.
However, net income for the quarter dropped mainly due to Respironics DOJ settlement provision.
In pre-market activity today, shares of Philips were trading at $28.78, up $1.20 or 4.35%.
In the third quarter, net income plunged to 28 million euros or 0.03 euro per share from last year's 187 million euros or 0.19 euro per share.
Income from operations fell to 165 million euros from 330 million euros last year, mainly due to a 288 million euros Respironics...